See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626199_2017_ALPINE_IMMUNE_SCIENCES_INC.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'IMMUNE DESIGN CORP.', 'shared_tokens': {'immune'}}]} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001626199')"} |
Graph
Absolute values for 0001626199, ALPINE IMMUNE SCIENCES INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 61,663,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 272,000 |
| 4 | LiabilitiesCurrent | 6,499,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,586,000 |
| 9 | ResearchAndDevelopmentExpense | 23,316,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 439,000 |
| 13 | remainder_ComprehensiveNetIncome | -20,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 61,935,000 |
| 1 | Liabilities | 6,499,000 |
| 2 | Expenses | 31,902,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 55,436,000 |
| 5 | NetIncome | -31,463,000 |
| 6 | ComprehensiveNetIncome | -31,473,000 |
| 7 | BaseVar | 50,397,500 |
| 8 | EconomicCapitalRatio | 1.87 |